Literature DB >> 15659426

Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo.

Paul Lingor1, Paulo Koeberle, Sebastian Kügler, Mathias Bähr.   

Abstract

Transection of the optic nerve induces an apoptotic degeneration of retinal ganglion cells (RGC) in the rat retina. The immediate early gene c-Jun, the proapoptotic Bcl-2 family member Bax and the apoptosome constituent Apaf-1 have been shown previously to play major roles in the induction or execution of the apoptosis cascade. In this study we have designed and generated short interfering RNAs (siRNAs) against c-Jun, Bax and Apaf-1, which were injected into the optic nerve stump in order to inhibit axotomy-induced apoptosis. siRNAs were first tested in vitro to ensure silencing efficiency. In vivo, a clear neuronal localization of Cy3-labelled siRNA could be visualized in retinal flat mounts. Retinas that were injected with anti-Apaf-1- and anti-c-Jun-siRNA showed significantly more surviving RGC than non-injected or anti-EGFP-injected controls (approximately 2- to 3-fold, respectively). Anti-Bax-siRNA-injected retinas showed a trend towards an increased RGC number (not significant). Regulation of target proteins in situ could be visualized by immunohistochemical stainings. We conclude that (i) c-Jun and Apaf-1 play major roles in the apoptotic cascade of RGC and may represent useful targets for antiapoptotic strategies in RGC in vivo, and (ii) injection of siRNAs into the optic nerve stump is a new method to down-regulate target genes specifically in RGC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659426     DOI: 10.1093/brain/awh382

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  41 in total

Review 1.  Therapeutic regulation of gene expression in the inner ear using RNA interference.

Authors:  Yukihide Maeda; Abraham M Sheffield; Richard J H Smith
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

Review 2.  Antisense makes sense in engineered regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang; Rohan R Varshney; Dong-An Wang
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 3.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

4.  Optic nerve transection: a model of adult neuron apoptosis in the central nervous system.

Authors:  Mark M Magharious; Philippe M D'Onofrio; Paulo D Koeberle
Journal:  J Vis Exp       Date:  2011-05-12       Impact factor: 1.355

Review 5.  Multiple transcription factor families regulate axon growth and regeneration.

Authors:  Darcie L Moore; Jeffrey L Goldberg
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

Review 6.  BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells.

Authors:  Margaret E Maes; Cassandra L Schlamp; Robert W Nickells
Journal:  Prog Retin Eye Res       Date:  2017-01-04       Impact factor: 21.198

7.  [Complement activation after induction of ocular hypertension in an animal model].

Authors:  S Becker; S Reinehr; H Burkhard Dick; S C Joachim
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

8.  Methods for experimental manipulations after optic nerve transection in the Mammalian CNS.

Authors:  Mark M Magharious; Philippe M D'Onofrio; Paulo D Koeberle
Journal:  J Vis Exp       Date:  2011-05-12       Impact factor: 1.355

Review 9.  Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation.

Authors:  D Ellenberg; J Shi; S Jain; J-H Chang; H Ripps; S Brady; E R Melhem; F Lakkis; A Adamis; D-F Chen; R Ellis-Behnke; R S Langer; S M Strittmatter; D T Azar
Journal:  Br J Ophthalmol       Date:  2009-03-13       Impact factor: 4.638

10.  The stargazin-related protein gamma 7 interacts with the mRNA-binding protein heterogeneous nuclear ribonucleoprotein A2 and regulates the stability of specific mRNAs, including CaV2.2.

Authors:  Laurent Ferron; Anthony Davies; Karen M Page; David J Cox; Jerôme Leroy; Dominic Waithe; Adrian J Butcher; Priya Sellaturay; Steven Bolsover; Wendy S Pratt; Fraser J Moss; Annette C Dolphin
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.